NanJing Pharmaceutical Company Limited

Shanghai Stock Exchange 600713.SS

NanJing Pharmaceutical Company Limited Free Cash Flow Per Share for the year ending December 31, 2023: USD 0.19

NanJing Pharmaceutical Company Limited Free Cash Flow Per Share is USD 0.19 for the year ending December 31, 2023, a 296.85% change year over year. Free cash flow per share is the free cash flow generated per share. Indicates investment potential based on cash flow generation.

NanJing Pharmaceutical Company Limited Free Cash Flow Per Share for the year ending December 31, 2022 was USD -0.10, a -264.76% change year over year.
NanJing Pharmaceutical Company Limited Free Cash Flow Per Share for the year ending December 31, 2021 was USD 0.06, a 128.54% change year over year.
NanJing Pharmaceutical Company Limited Free Cash Flow Per Share for the year ending December 31, 2020 was USD -0.21, a -312.30% change year over year.
NanJing Pharmaceutical Company Limited Free Cash Flow Per Share for the year ending December 31, 2019 was USD 0.10, a 199.91% change year over year.

Key data

Date	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)

Shanghai Stock Exchange: 600713.SS

NanJing Pharmaceutical Company Limited

CEO	Mr. Liang Zhang
IPO Date	July 1, 1996
Location	China
Headquarters	Building A
Employees	4,903
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Retail & Wholesale

Description

NanJing Pharmaceutical Company Limited engages pharmaceutical wholesale and retail businesses in China. It also operates approximately 510 pharmacy retail stores and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.

Key trends

Past 5 years